Literature DB >> 3864439

Potent inhibition of mammalian progesterone synthesis by 2 alpha-cyanoprogesterone.

R B Sharp, M B Senior, T M Penning.   

Abstract

2 alpha-Cyanoprogesterone potently inhibits the conversion of [3H]pregnenolone into progesterone catalysed by bovine corpora lutea, bovine adrenal cortex and human term placenta microsomes (microsomal fractions), yielding IC50 (concentration causing 50% inhibition) values of 66 nM, 120 nM and 700 nM respectively. By contrast, it is an exceedingly poor inhibitor of the isomerization of pregn-5-ene-3,20-dione, yielding IC50 values between 50 and 70 microM. On this basis, 2 alpha-cyanoprogesterone would appear to be an extraordinarily selective inhibitor of the 3 beta-hydroxysteroid dehydrogenase. Dixon plots indicate that it is a very-tight-binding competitive inhibitor of the corpus-luteum enzyme, yielding a Ki of 15 nM. In the bovine adrenal cortex and human placenta the steroid is less potent and inhibits the dehydrogenase non-competitively with Ki values of 150 nM and 1.0 microM respectively. Thus 2 alpha-cyanoprogesterone inhibits the corpus-luteum dehydrogenase with substantial selectivity. Because of its high affinity for the ovarian enzyme, the presence of low-micromolar concentrations of 2 alpha-cyanoprogesterone can promote a complete cessation of progesterone synthesis in corpora-lutea microsomes for several hours. Since this effect is observed in the presence of saturating concentrations of pregnenolone (50 microM), it is predicted that this inhibitor may be even more potent in vivo. 2 alpha-Cyanoprogesterone displays very low affinity for the human progesterone receptor, yielding a Kd of 600 nM as against a Kd of 1.6 nM for progesterone. It is suggested that 2 alpha-cyanoprogesterone may be a selective inhibitor of ovarian progesterone synthesis and may act as an effective anti-gestational agent in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3864439      PMCID: PMC1152659          DOI: 10.1042/bj2300587

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  9 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  "Unbound" ligand adsorption on dextran-coated charcoal: practical considerations.

Authors:  R de Hertogh; I van der Heyden; E Ekka
Journal:  J Steroid Biochem       Date:  1975-09       Impact factor: 4.292

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Induction of preterm labor in the rat by antiprogesterone.

Authors:  A I Csapo; B A Resch
Journal:  Am J Obstet Gynecol       Date:  1979-08-01       Impact factor: 8.661

5.  Further studies of steoidal inhibitors of delpha5, 3beta-hydroxysteroid dehydrogenase and delta5-delta4, 3-ketosteroid isomerase in Pseudomonas testosteroni and in bovine adrenals.

Authors:  A S Goldman
Journal:  J Clin Endocrinol Metab       Date:  1968-11       Impact factor: 5.958

6.  Effects of antiprogesterone on pregnancy. I. Midpregnancy.

Authors:  A I Csapo; B Resch; E F Csapo; G Salau
Journal:  Am J Obstet Gynecol       Date:  1979-01-15       Impact factor: 8.661

7.  Prevention of implantation by antiprogesterone.

Authors:  A I Csapo; B Resch
Journal:  J Steroid Biochem       Date:  1979-07       Impact factor: 4.292

8.  Persistent effects of a synthetic androstene derivative on activities of 3-beta-hydroxysteroid dehydrogenase and glucose-6-phosphate dehydrogenase in rats.

Authors:  A S Goldman; W C Yakovac; A M Bongiovanni
Journal:  Endocrinology       Date:  1965-12       Impact factor: 4.736

9.  Irreversible inhibition of delta 5-3-oxosteroid isomerase by 2-substituted progesterones.

Authors:  T M Penning
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.